CR20140325A - Nuevos derivados de morofolinilo útiles como inhibodores de mogat-2- - Google Patents
Nuevos derivados de morofolinilo útiles como inhibodores de mogat-2-Info
- Publication number
- CR20140325A CR20140325A CR20140325A CR20140325A CR20140325A CR 20140325 A CR20140325 A CR 20140325A CR 20140325 A CR20140325 A CR 20140325A CR 20140325 A CR20140325 A CR 20140325A CR 20140325 A CR20140325 A CR 20140325A
- Authority
- CR
- Costa Rica
- Prior art keywords
- morofolinyl
- mogat
- inhibitors
- derivatives
- new useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a compuestos de Fórmula I, o una sal farmacéutica de los mismos, métodos para tratar hipertrigliceridemia usando los compuestos; y a un proceso para preparar los compuestos. WO 2013/116065 A1.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12382037 | 2012-01-31 | ||
US201261617093P | 2012-03-29 | 2012-03-29 | |
EP12382433 | 2012-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20140325A true CR20140325A (es) | 2014-08-25 |
Family
ID=48905712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20140325A CR20140325A (es) | 2012-01-31 | 2014-07-08 | Nuevos derivados de morofolinilo útiles como inhibodores de mogat-2- |
Country Status (24)
Country | Link |
---|---|
US (1) | US8993568B2 (es) |
EP (1) | EP2809661B1 (es) |
JP (1) | JP5852269B2 (es) |
KR (1) | KR20140107641A (es) |
CN (1) | CN104080777B (es) |
AP (1) | AP2014007793A0 (es) |
AU (1) | AU2013215549B2 (es) |
BR (1) | BR112014018712A8 (es) |
CA (1) | CA2859992A1 (es) |
CL (1) | CL2014001862A1 (es) |
CO (1) | CO7020914A2 (es) |
CR (1) | CR20140325A (es) |
DO (1) | DOP2014000177A (es) |
EA (1) | EA024182B1 (es) |
ES (1) | ES2571577T3 (es) |
GT (1) | GT201400169A (es) |
HK (1) | HK1199024A1 (es) |
IL (1) | IL233542A0 (es) |
MX (1) | MX2014008604A (es) |
PE (1) | PE20141789A1 (es) |
PH (1) | PH12014501712B1 (es) |
SG (1) | SG11201404508XA (es) |
WO (1) | WO2013116065A1 (es) |
ZA (1) | ZA201405227B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013112323A1 (en) | 2012-01-23 | 2013-08-01 | Eli Lilly And Company | Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors |
AR089771A1 (es) | 2012-01-31 | 2014-09-17 | Lilly Co Eli | Derivados de bencil sulfonamida utiles como inhibidores de mogat-2 |
US8993568B2 (en) | 2012-01-31 | 2015-03-31 | Eli Lilly And Company | Morpholinyl derivatives useful as MOGAT-2 inhibitors |
EA201590696A1 (ru) | 2012-11-06 | 2015-08-31 | Эли Лилли Энд Компани | Новые бензилсульфонамидные соединения, подходящие в качестве ингибиторов mogat-2 |
EP3395798A4 (en) | 2015-12-21 | 2019-07-17 | Shionogi & Co., Ltd | NON-AROMATIC HETEROCYCLIC DERIVATIVE HAVING MGAT2 INHIBITORY ACTIVITY |
TWI782056B (zh) | 2017-07-14 | 2022-11-01 | 日商鹽野義製藥股份有限公司 | 具有mgat2抑制活性的縮合環衍生物 |
KR20210114001A (ko) | 2019-01-11 | 2021-09-17 | 시오노기 앤드 컴파니, 리미티드 | Mgat2 저해 활성을 갖는 다이하이드로피라졸로피라지논 유도체 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
US6387954B1 (en) | 1998-07-31 | 2002-05-14 | Eli Lilly And Company | Alkenyl sulphonamide derivatives |
AU5235699A (en) | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | Sulfonamide derivatives |
GB0408777D0 (en) | 2004-04-20 | 2004-05-26 | Glaxo Group Ltd | Compounds |
EP1659113A1 (en) | 2004-11-08 | 2006-05-24 | Evotec AG | Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1) |
EP1655283A1 (en) | 2004-11-08 | 2006-05-10 | Evotec OAI AG | 11beta-HSD1 Inhibitors |
WO2008038768A1 (fr) | 2006-09-28 | 2008-04-03 | Dainippon Sumitomo Pharma Co., Ltd. | Composé ayant une structure de pyrimidine bicyclique et composition pharmaceutique comprenant le composé |
TW200831092A (en) * | 2006-12-21 | 2008-08-01 | Astrazeneca Ab | Therapeutic agents |
EP2240447A2 (en) * | 2007-12-05 | 2010-10-20 | AstraZeneca AB (Publ) | Morpholine derivates as antiobesity agents |
AU2008345225A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
JPWO2009119726A1 (ja) | 2008-03-28 | 2011-07-28 | Msd株式会社 | メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体 |
EP2313096A1 (en) | 2008-06-04 | 2011-04-27 | AstraZeneca AB (Publ) | New compounds v |
EP2398800A4 (en) | 2009-02-23 | 2012-07-25 | Msd Kk | Pyrimidin-4 (3H) -ONE DERIVATIVES |
JP2014051434A (ja) | 2010-12-28 | 2014-03-20 | Dainippon Sumitomo Pharma Co Ltd | 二環性ピリミジン誘導体 |
WO2013112323A1 (en) | 2012-01-23 | 2013-08-01 | Eli Lilly And Company | Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors |
US8993568B2 (en) | 2012-01-31 | 2015-03-31 | Eli Lilly And Company | Morpholinyl derivatives useful as MOGAT-2 inhibitors |
AR089771A1 (es) | 2012-01-31 | 2014-09-17 | Lilly Co Eli | Derivados de bencil sulfonamida utiles como inhibidores de mogat-2 |
EA201590696A1 (ru) | 2012-11-06 | 2015-08-31 | Эли Лилли Энд Компани | Новые бензилсульфонамидные соединения, подходящие в качестве ингибиторов mogat-2 |
-
2013
- 2013-01-24 US US14/372,833 patent/US8993568B2/en not_active Expired - Fee Related
- 2013-01-24 PE PE2014001194A patent/PE20141789A1/es not_active Application Discontinuation
- 2013-01-24 SG SG11201404508XA patent/SG11201404508XA/en unknown
- 2013-01-24 AP AP2014007793A patent/AP2014007793A0/xx unknown
- 2013-01-24 CN CN201380007113.8A patent/CN104080777B/zh not_active Expired - Fee Related
- 2013-01-24 AU AU2013215549A patent/AU2013215549B2/en not_active Ceased
- 2013-01-24 EP EP13702564.9A patent/EP2809661B1/en active Active
- 2013-01-24 WO PCT/US2013/022828 patent/WO2013116065A1/en active Application Filing
- 2013-01-24 EA EA201491227A patent/EA024182B1/ru not_active IP Right Cessation
- 2013-01-24 CA CA2859992A patent/CA2859992A1/en not_active Abandoned
- 2013-01-24 BR BR112014018712A patent/BR112014018712A8/pt not_active IP Right Cessation
- 2013-01-24 ES ES13702564T patent/ES2571577T3/es active Active
- 2013-01-24 KR KR1020147021129A patent/KR20140107641A/ko active IP Right Grant
- 2013-01-24 JP JP2014554806A patent/JP5852269B2/ja not_active Expired - Fee Related
- 2013-01-24 MX MX2014008604A patent/MX2014008604A/es unknown
-
2014
- 2014-07-07 IL IL233542A patent/IL233542A0/en unknown
- 2014-07-08 CR CR20140325A patent/CR20140325A/es unknown
- 2014-07-15 CL CL2014001862A patent/CL2014001862A1/es unknown
- 2014-07-16 ZA ZA2014/05227A patent/ZA201405227B/en unknown
- 2014-07-24 CO CO14161421A patent/CO7020914A2/es unknown
- 2014-07-29 GT GT201400169A patent/GT201400169A/es unknown
- 2014-07-30 PH PH12014501712A patent/PH12014501712B1/en unknown
- 2014-07-30 DO DO2014000177A patent/DOP2014000177A/es unknown
- 2014-12-11 HK HK14112464.6A patent/HK1199024A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2809661B1 (en) | 2016-04-06 |
EP2809661A1 (en) | 2014-12-10 |
ES2571577T3 (es) | 2016-05-26 |
AP2014007793A0 (en) | 2014-07-31 |
KR20140107641A (ko) | 2014-09-04 |
DOP2014000177A (es) | 2014-08-31 |
PH12014501712A1 (en) | 2014-10-13 |
SG11201404508XA (en) | 2014-10-30 |
EA201491227A1 (ru) | 2015-01-30 |
CA2859992A1 (en) | 2013-08-08 |
JP5852269B2 (ja) | 2016-02-03 |
CN104080777B (zh) | 2015-12-09 |
MX2014008604A (es) | 2014-08-22 |
PE20141789A1 (es) | 2014-11-19 |
US20150005305A1 (en) | 2015-01-01 |
EA024182B1 (ru) | 2016-08-31 |
CL2014001862A1 (es) | 2014-11-14 |
AU2013215549A1 (en) | 2014-07-17 |
CN104080777A (zh) | 2014-10-01 |
JP2015504917A (ja) | 2015-02-16 |
BR112014018712A8 (pt) | 2017-07-11 |
BR112014018712A2 (es) | 2017-06-20 |
US8993568B2 (en) | 2015-03-31 |
IL233542A0 (en) | 2014-08-31 |
ZA201405227B (en) | 2016-05-25 |
HK1199024A1 (zh) | 2015-06-19 |
PH12014501712B1 (en) | 2014-10-13 |
CO7020914A2 (es) | 2014-08-11 |
WO2013116065A1 (en) | 2013-08-08 |
GT201400169A (es) | 2015-08-27 |
AU2013215549B2 (en) | 2015-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20140325A (es) | Nuevos derivados de morofolinilo útiles como inhibodores de mogat-2- | |
CY1118681T1 (el) | Αναστολεις νεπριλυσινης | |
CR20160212A (es) | Composiciones y métodos para modular los receptores x farnesoides | |
CR20150078A (es) | Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
GT201400022A (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinolina util para el tratamiento de diabetes | |
GT201400063A (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
UY35683A (es) | Polimorfo de inhibidores de tirosina quinasa de bazo (syk) | |
EA201401292A3 (ru) | Новые тиенопиримидиновые производные, способ их получения и фармацевтические композиции, содержащие их | |
CR20150370A (es) | Compuestos antivirales | |
BR112016014020A8 (pt) | moduladores de tetra-hidropiridopirazinas de gpr6. | |
EA201492040A1 (ru) | Бициклически замещённые урацилы и их применение | |
MX2015007916A (es) | Peri-carbinoles. | |
DOP2014000178A (es) | Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2 | |
DOP2017000034A (es) | Compuestos de imidazopiridazina | |
CL2014002661A1 (es) | Compuestos derivados de tienopirimidina o sus sales, como inhibidores de la alk quinasa; su proceso de preparacion; composicion farmaceutica que los comprende, util para el tratamiento del cancer. | |
CR20140553A (es) | Compuestos de fenoxietil piperidina | |
NI201200195A (es) | Procedimiento de preparación de la sal de l - arginina de perindoprilo | |
UY33461A (es) | Compuestos heterocíclicos, su preparación y su aplicación terapéutica | |
EA201590656A1 (ru) | Азаиндолины | |
EA201590696A1 (ru) | Новые бензилсульфонамидные соединения, подходящие в качестве ингибиторов mogat-2 | |
CR20150160A (es) | Derivados de macrólidos, su preparación y su uso terapéutico | |
AR098134A1 (es) | Compuestos de urea | |
CR20140130A (es) | 2-(croman-6-iloxi)-tiazoles sustituidos y su uso como productos farmacéuticos | |
EA201501177A1 (ru) | Фармацевтические композиции | |
UY33973A (es) | Métodos de tratamiento dirigido de degeneración lobular frontotemporal. |